73406-50-5

Basic information

• Product Name: ethyl 3-hydroxypicolinate
• Synonyms: ethyl 3-hydroxypicolinate;3-HYDROXYPYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER;Ethyl 3-hydroxy-2-pyridinecarboxylate
• CAS NO: 73406-50-5
• Molecular Formula: C₈H₉NO₃
• Molecular Weight: 167.163
• Mol File: 73406-50-5.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 345.924°C at 760 mmHg
• Flash Point: 163.009°C
• Appearance: /
• Density: 1.234g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.542
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: ethyl 3-hydroxypicolinate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-hydroxypicolinate(73406-50-5)
• EPA Substance Registry System: ethyl 3-hydroxypicolinate(73406-50-5)

Safety Data

• Hazardous Substances Data: 73406-50-5(Hazardous Substances Data)

Usage

General Description

Ethyl 3-hydroxypicolinate is a chemical compound often used in the research and development phase in various industries, such as pharmaceuticals. It is an intermediate in organic synthesis, implying that it is used in the creation of a myriad of other, more complex chemical substances. Its molecular formula is C8H9NO3, and its systematic name is ethyl 3-hydroxy-2-pyridinecarboxylate. It appears as a transparent to light yellow liquid and needs to be handled with care due to its potentially hazardous nature. Its stoichiometric characteristics make it reactive and thus versatile for different chemical reactions.

InChI:InChI=1/C8H9NO3/c1-2-12-8(11)7-6(10)4-3-5-9-7/h3-5,10H,2H2,1H3

Upstream product

• 874-24-8 3-hydroxypyridine-2-carboxylic acid 
• 164254-29-9 Ethyl 2-diazo-3,6-dioxohexanoate 
• 122060-92-8 6-hydroxy-2-diazo-3-oxo-hexanoic acid ethyl ester 
• 75-03-6 ethyl iodide 
• 164254-26-6 (E)-Ethyl 2-diazo-5-<(methoxyimino)methyl>-3-oxopentanoate 
• 762-42-5 dimethyl acetylenedicarboxylate 
• 64-17-5 ethanol 

Downstream Products

• 1443209-10-6 2-(3-benzyl-1,2,4-oxadiazol-5-yl)-3-(piperidin-4-yloxy)pyridine 
• 81376-88-7 2-acetyl-3-ethoxypyridine 
• 107095-99-8 ethyl 3-hydroxyfuro<3,2-b>pyridine-2-carboxylate 
• 107096-09-3 3-methyl-furo[3,2-b]-pyridine-2-carboxylic acid 
• 107096-03-7 2-methylfuro<3,2-b>pyridin-3(2H)-one 
• 107096-01-5 3-hydroxy-2,3-dihydrofuro<3,2-b>pyridine 
• 107096-11-7 3-methylfuro<3,2-b>pyridine 
• 13210-29-2 1-(3-hydroxypyridin-2-yl)ethan-1-one 
• 272-62-8 furo[3,2-b]pyridine 
• 123470-87-1 3-(thiophenoxymethoxy)picolinic acid 
• 147894-77-7 2-(2-phenoxyethoxy)picolinic acid 
• 1026379-91-8 [3-(tert-butyl-dimethyl-silanyloxy)-pyridin-2-yl]-(4-fluoro-phenyl)-methanone 
• 223743-23-5 ethyl-2-[2-(4-fluorobenzoyl)pyridin-3-yloxy]acetate 
• 223743-26-8 2-carboxy-3-(4-fluorophenyl)-furo[3,2-b]pyridine 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION

The present disclosure relates generally to compounds and pharmaceutical compositions for the selective inhibition of histone lysine demethylase5 (KDM5), particularly KDM5B, and methods of their use in treating conditions and diseases associated with KDM5 activity.

BENZOFURAN AMIDES AND HETEROAROMATIC ANALOGUES THEREOF FOR USE IN THERAPY

The present invention relatesto a pharmaceutical composition comprising acompound of the formula Ias described belowor a tautomeror a pharmaceutically acceptable salt thereof; to the compound of the formula Ias described below or a tautomer or a phar- mac

Novel 3beta-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof

The invention concerns compounds of general formula 1, wherein: A, B, D and E represent one or two nitrogen atoms, the others being carbon atoms; X represents a S or, a O, thereby forming a bicyclic fused heteroaromatic, such as thieno[2,3-b]pyridine, furo[2,3-b]pyridine, thieno[3,2-b]pyridine, furo[3,2-b]pyridine, thieno[2,3-b]pyrazine, furo[2,3-b]pyrazine, thieno[2,3-c]pyridine, furo[2,3-c]pyridine, thieno[3,2-c]pyridine and furo[3,2-c]pyridine; R1 represents a linear or branched C1-C6 alkoxy group, a linear or branched C1-C6 alkylthio group; R2 represents a linear, branched, cyclic C2-C8 group, a 2- or 3- thienylmethyl group, or a benzyl group optionally substituted by one or several halogens, F, Cl, Br, I, C1-C4 alkyl, C1-C4 alkoxy, CF3, CN, NO2, OH; and their pharmaceutically acceptable salts. Said compounds are anti-dopaminergic agents.